Pooled Proportions of Individuals With Latent Tuberculosis Infection and Specified Lesions on Chest Radiography
| Characteristics . | N Studies [reference number] . | N Individualsa . | (Pooled) Proportion of Individuals With Lesions on CXRb (95% CI) . | Heterogeneity . |
|---|---|---|---|---|
| Patients with LTBI | ||||
| Pleural thickening | 9 [19–21, 23, 26, 27, 33, 37, 39] | 12 883 | 0.02 (0.01; 0.03) | I2 = 95%, τ 2 = 0.004 |
| Calcified nodule | 7 [19–21, 23, 26, 33, 39] | 7108 | 0.07 (0.02; 0.15) | I2 = 99%, τ 2 = 0.029 |
| Noncalcified nodule | 6 [19–21, 23, 33, 39] | 6573 | 0.01 (0.00; 0.02) | I2 = 86%, τ 2 = 0.002 |
| Fibrotic scarring | 7 [19–21, 23, 26, 33, 39] | 7108 | 0.02 (0.01; 0.05) | I2 = 96%, τ 2 = 0.007 |
| Patients without LTBI | ||||
| Pleural thickening | 2 [37, 39] | 3039 | 0.01 (0.00; 0.04) | I2 = 96%, τ 2 = 0.007 |
| Calcified nodule | 1 [39] | 568 | 0 | NE |
| Noncalcified nodule | 1 [39] | 568 | 0 | NE |
| Fibrotic scarring | 1[39] | 568 | 0 | NE |
| Characteristics . | N Studies [reference number] . | N Individualsa . | (Pooled) Proportion of Individuals With Lesions on CXRb (95% CI) . | Heterogeneity . |
|---|---|---|---|---|
| Patients with LTBI | ||||
| Pleural thickening | 9 [19–21, 23, 26, 27, 33, 37, 39] | 12 883 | 0.02 (0.01; 0.03) | I2 = 95%, τ 2 = 0.004 |
| Calcified nodule | 7 [19–21, 23, 26, 33, 39] | 7108 | 0.07 (0.02; 0.15) | I2 = 99%, τ 2 = 0.029 |
| Noncalcified nodule | 6 [19–21, 23, 33, 39] | 6573 | 0.01 (0.00; 0.02) | I2 = 86%, τ 2 = 0.002 |
| Fibrotic scarring | 7 [19–21, 23, 26, 33, 39] | 7108 | 0.02 (0.01; 0.05) | I2 = 96%, τ 2 = 0.007 |
| Patients without LTBI | ||||
| Pleural thickening | 2 [37, 39] | 3039 | 0.01 (0.00; 0.04) | I2 = 96%, τ 2 = 0.007 |
| Calcified nodule | 1 [39] | 568 | 0 | NE |
| Noncalcified nodule | 1 [39] | 568 | 0 | NE |
| Fibrotic scarring | 1[39] | 568 | 0 | NE |
Abbreviations: CXR, chest radiography; LTBI, latent tuberculosis infection; NE, not estimated.
a Number of individuals with LTBI based on tuberculin skin test or interferon gamma release assay result.
b Only pooled if more than 1 study examined a certain characteristic.
Pooled Proportions of Individuals With Latent Tuberculosis Infection and Specified Lesions on Chest Radiography
| Characteristics . | N Studies [reference number] . | N Individualsa . | (Pooled) Proportion of Individuals With Lesions on CXRb (95% CI) . | Heterogeneity . |
|---|---|---|---|---|
| Patients with LTBI | ||||
| Pleural thickening | 9 [19–21, 23, 26, 27, 33, 37, 39] | 12 883 | 0.02 (0.01; 0.03) | I2 = 95%, τ 2 = 0.004 |
| Calcified nodule | 7 [19–21, 23, 26, 33, 39] | 7108 | 0.07 (0.02; 0.15) | I2 = 99%, τ 2 = 0.029 |
| Noncalcified nodule | 6 [19–21, 23, 33, 39] | 6573 | 0.01 (0.00; 0.02) | I2 = 86%, τ 2 = 0.002 |
| Fibrotic scarring | 7 [19–21, 23, 26, 33, 39] | 7108 | 0.02 (0.01; 0.05) | I2 = 96%, τ 2 = 0.007 |
| Patients without LTBI | ||||
| Pleural thickening | 2 [37, 39] | 3039 | 0.01 (0.00; 0.04) | I2 = 96%, τ 2 = 0.007 |
| Calcified nodule | 1 [39] | 568 | 0 | NE |
| Noncalcified nodule | 1 [39] | 568 | 0 | NE |
| Fibrotic scarring | 1[39] | 568 | 0 | NE |
| Characteristics . | N Studies [reference number] . | N Individualsa . | (Pooled) Proportion of Individuals With Lesions on CXRb (95% CI) . | Heterogeneity . |
|---|---|---|---|---|
| Patients with LTBI | ||||
| Pleural thickening | 9 [19–21, 23, 26, 27, 33, 37, 39] | 12 883 | 0.02 (0.01; 0.03) | I2 = 95%, τ 2 = 0.004 |
| Calcified nodule | 7 [19–21, 23, 26, 33, 39] | 7108 | 0.07 (0.02; 0.15) | I2 = 99%, τ 2 = 0.029 |
| Noncalcified nodule | 6 [19–21, 23, 33, 39] | 6573 | 0.01 (0.00; 0.02) | I2 = 86%, τ 2 = 0.002 |
| Fibrotic scarring | 7 [19–21, 23, 26, 33, 39] | 7108 | 0.02 (0.01; 0.05) | I2 = 96%, τ 2 = 0.007 |
| Patients without LTBI | ||||
| Pleural thickening | 2 [37, 39] | 3039 | 0.01 (0.00; 0.04) | I2 = 96%, τ 2 = 0.007 |
| Calcified nodule | 1 [39] | 568 | 0 | NE |
| Noncalcified nodule | 1 [39] | 568 | 0 | NE |
| Fibrotic scarring | 1[39] | 568 | 0 | NE |
Abbreviations: CXR, chest radiography; LTBI, latent tuberculosis infection; NE, not estimated.
a Number of individuals with LTBI based on tuberculin skin test or interferon gamma release assay result.
b Only pooled if more than 1 study examined a certain characteristic.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
